Mumbai: Drug firm Sun Pharma today said it has received US regulatory approval to market Roxicodone, Oxycodone hydrochloride tablets used as painkillers.
In a filing to the Bombay Stock Exchange, Sun Pharmaceutical Industries said its subsidiary has received US Food and Drug Administration approval (USFDA) to market Roxicodone, Oxycodone hydrochloride tablets used as a painkiller.
The tablets are in the strength of 5mg, 15mg and 30mg and is used as a narcotic painkiller in the treatment of moderate to severe pain. These products would reach the US market shortly, the filing added.
Shares of Sun Pharmaceutical were trading at Rs1,145.50, up 1.63% on the BSE.